Compare LEXX & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | GFAI |
|---|---|---|
| Founded | 2004 | 2018 |
| Country | Canada | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 19.4M |
| IPO Year | N/A | N/A |
| Metric | LEXX | GFAI |
|---|---|---|
| Price | $0.70 | $0.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.50 | ★ $4.50 |
| AVG Volume (30 Days) | ★ 1.5M | 335.2K |
| Earning Date | 01-13-2026 | 09-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $36,987,715.00 |
| Revenue This Year | $13.35 | $5.66 |
| Revenue Next Year | $78.83 | $4.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 52.05 | 4.38 |
| 52 Week Low | $0.46 | $0.54 |
| 52 Week High | $2.43 | $3.88 |
| Indicator | LEXX | GFAI |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 41.50 |
| Support Level | $0.46 | $0.62 |
| Resistance Level | $0.72 | $0.80 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 58.20 | 40.38 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.